Cibus, Inc. (CBUS) vs OnKure Therapeutics, Inc. (OKUR)
Cibus, Inc. and OnKure Therapeutics, Inc. are both Biotechnology companies. Cibus, Inc. and OnKure Therapeutics, Inc. are of similar size ($118.7M and $114.6M). OnKure Therapeutics, Inc. has the higher net margin (0.00% vs −2,258.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, OnKure Therapeutics, Inc. leads on 8 and Cibus, Inc. on 5.
Valuation
Profitability
| Metric | CBUS | OKUR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (1,450.59%) | 0.00% | 0.00% |
| Net margin | (2,258.89%) | 0.00% | 0.00% |
| Free cash flow margin | (1,064.60%) | 0.00% | 0.00% |
| Return on equity | (219.97%) | (46.91%) | (57.72%) |
| Return on assets | (29.77%) | (44.24%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack